Online learning

CPD accredited online module to help you manage your male patients’ health.

Welcome to this interactive educational portal which is brought to you by the Bayer Men’s Health team in association with the British Society for Sexual Medicine (BSSM).

These e-learning modules are intended for UK healthcare professionals in the fields of general practice, urology, endocrinology, cardiology, sexual medicine and psychotherapy, and for any healthcare professional who is involved in the management of men's health issues.

Screening and Diagnosis of Testosterone Deficiency (TD)

This e-learning module is comprised of case studies reinforcing the principles covered in the webinar ‘An Overview of Testosterone Deficiency’ with particular emphasis on how to screen male patients for TD, distinguishing between primary and secondary hypogonadism, and considerations for selecting patients appropriately for testosterone replacement therapy.

Start module

Understanding Erectile Dysfunction

Through a series of case studies, participants are encouraged to consider the multiple aetiologies of erectile dysfunction (including testosterone deficiency), relevant routes of investigation, as well as management options.

Start module

Testosterone Replacement Therapy (TRT) and Monitoring

Through a series of case studies, this e-learning module, which supplements the themes addressed in the webinar ‘An Overview of Testosterone Deficiency’, will emphasise counselling male hypogonadal patients on testosterone replacement therapy (TRT), a summary of potential options for TRT, as well as how to monitor men once they are commenced on TRT.

Start module

Restore the man is organised and funded by Bayer and may contain some promotional content.

Licensed for:
In the UK, Nebido® (testosterone undecanoate) is Licensed for testosterone replacement therapy for male hypogonadism when testosterone deficiency has been confirmed by clinical features and biochemical tests.

This website is intended for Healthcare Professionals resident in the UK.